Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase
文献类型:期刊论文
作者 | Wang, Yue-Hu1![]() ![]() |
刊名 | CHEMISTRY CENTRAL JOURNAL
![]() |
出版日期 | 2012-09-08 |
卷号 | 6 |
关键词 | Amaryllidaceae alkaloids Lycorine Acetylcholinesterase Butyrylcholinesterase |
英文摘要 | Background: Alzheimer's disease (AD) is a neurologically degenerative disorder that affects more than 20 million people worldwide. The selective butyrylcholinesterase (BChE) inhibitors and bivalent cholinesterase (ChE) inhibitors represent new treatments for AD. |
类目[WOS] | Chemistry, Multidisciplinary |
研究领域[WOS] | Chemistry |
关键词[WOS] | AMARYLLIDACEAE ALKALOIDS ; ALZHEIMERS-DISEASE ; HOSTA-PLANTAGINEA ; PEPTIDE |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000312632100001 |
公开日期 | 2015-07-07 |
源URL | [http://ir.kib.ac.cn/handle/151853/20074] ![]() |
专题 | 昆明植物研究所_资源植物与生物技术所级重点实验室 |
作者单位 | 1.Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming 650201, Peoples R China 2.Minzu Univ China, Coll Life & Environm Sci, Beijing 100081, Peoples R China 3.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650201, Peoples R China 4.Nanjing Univ, Sch Chem & Chem Engn, Nanjing 210093, Jiangsu, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Yue-Hu,Wan, Qin-Li,Gu, Cheng-Ding,et al. Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase[J]. CHEMISTRY CENTRAL JOURNAL,2012,6. |
APA | Wang, Yue-Hu,Wan, Qin-Li,Gu, Cheng-Ding,Luo, Huai-Rong,&Long, Chun-Lin.(2012).Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase.CHEMISTRY CENTRAL JOURNAL,6. |
MLA | Wang, Yue-Hu,et al."Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase".CHEMISTRY CENTRAL JOURNAL 6(2012). |
入库方式: OAI收割
来源:昆明植物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。